Harbinger Health

Biotechnology company developing blood-based multi-cancer detection tests designed to resolve diagnostic uncertainty when cancer is suspected.

Back to company catalog

Cancer Detection · cfDNA methylation / machine learning · Pre-commercial; planned 2026 launch

Compare report options